MyFinsight
Home
Blog
About
Selling, general and
administrative
$82,008K
(18.80%↑ Y/Y)
Research and development
compensation and...
$11,366K
(16.23%↑ Y/Y)
Cost of sales
$10,376K
(49.75%↑ Y/Y)
Other segment
expenses
$6,295K
(14.27%↑ Y/Y)
Research and
development-Topical Roflumilast...
$1,983K
(-29.85%↓ Y/Y)
Research and
development-ARQ234Program Costs
$1,302K
Research and
development-Other Program Costs
$102K
Total operating
expenses
$113,432K
(18.02%↑ Y/Y)
Income (gain) from
operations
$16,429K
(212.44%↑ Y/Y)
Total revenues
$129,861K
(59.33%↑ Y/Y)
Income (gain) from
operations
$16,429K
(212.44%↑ Y/Y)
Total operating
expenses
$113,432K
(18.02%↑ Y/Y)
Income (gain) before
income taxes
$15,145K
(197.43%↑ Y/Y)
Total other income
(expense)
-$1,284K
Interest income
$2,279K
Selling, general and
administrative
$82,138K
(18.75%↑ Y/Y)
Research and development
$20,355K
(4.64%↑ Y/Y)
Cost of sales
$10,939K
(46.01%↑ Y/Y)
Segment and
consolidated net income...
$15,009K
(194.48%↑ Y/Y)
Provision for income taxes
$136K
(-60.23%↓ Y/Y)
Interest expense
$3,406K
(12.45%↑ Y/Y)
Other income
(expense), net
-$157K
(-107.49%↓ Y/Y)
Comprehensive income (gain)
$14,867K
(194.21%↑ Y/Y)
Total other
comprehensive income (gain)
-$142K
(-235.24%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
-$96K
(-1.05%↓ Y/Y)
Foreign currency
translation adjustment
-$46K
(-123.00%↓ Y/Y)
Back
Back
Income Statement
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)
logo-arcutis (1)-svg
source: myfinsight.com
Arcutis Biotherapeutics, Inc. (ARQT)